Franck Charles Marie Grimaud is a businessperson who founded Vivalis SA and who has been at the head of 8 different companies. Currently, Mr. Grimaud is Chief Executive Officer & Director at Atlantic Biotherapies.
He is also Co-President & Chief Business Officer at Valneva SE, Managing Director at Valneva Austria GmbH and Chief Business Officer for Intercell Austria AG and on the board of 5 other companies.
In his past career he occupied the position of President & Managing Director at Smol Therapeutics SAS, Chairman for Vivalis Toyama Japan KK and President & Chief Executive Officer at Vivalis SA.
Mr. Grimaud received an MBA from the University of Ottawa.